Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial
Author(s): Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, et al.
Efficacy and Mechanism Evaluation. Southampton (UK): NIHR Journals Library; 2015.
NIHR Acknowledged: No